Mark E. Hensley

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cary, NC
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Kathryn Lester Attorney-in-Fact for Mark E. Hensley
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Mark E. Hensley

Form 4 holding Chief Operating Officer

HERON THERAPEUTICS, INC. /DE/

Security class
Employee Performance Stock Option (Right to Buy)
Shares / value
900,000
Estimated value
$1,980,000
Report date
28 Apr 2025
Price
$2.20
Ownership
Direct
Underlying class
Common Stock
Underlying amount
900,000
Form 4 holding Chief Operating Officer

HERON THERAPEUTICS, INC. /DE/

Security class
Employee Stock Option (Right to Buy)
Shares / value
500,000
Estimated value
$1,100,000
Report date
28 Apr 2025
Price
$2.20
Ownership
Direct
Underlying class
Common Stock
Underlying amount
500,000

Insider Reports Filed by Mark E. Hensley

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .